Search results
Jan 24, 2022 · Harrisburg − January 24, 2022 – The Pennsylvania Senate Aging and Youth Committee today unanimously approved Senator Lisa Boscola’s legislation (Senate Bill 936) that would mandate the reporting of any infant born with an addiction to opioids.
A newborn with a clinical diagnosis in the neonatal period (birth up to 28 days of life) who has symptoms of withdrawal because of prenatal exposure to opiate drugs, either via prescription, medical therapy (MAT), or illegal use (ICD-10 codes P96.1 and P04.49 only, if available);
Effective January 1, 2020, all hospitals in Pennsylvania are required to report NAS cases in Pennsylvania residents’ newborns (neonates that are less than 28 days old) showing withdrawal symptoms due to in utero exposure to opioids, benzodiazepines, or barbiturates
Feb 8, 2022 · On February 2, 2022, that opportunity only increased as a result of a letter from the Department of Justice to the Supreme Court of Pennsylvania and its Administrative Office of Pennsylvania courts.
May 17, 2022 · "Neonatal abstinence syndrome" or "NAS." A withdrawal syndrome of an infant that occurs when an infant is born after exposure to drugs, including opioids in utero, and that is associated with multiple side effects, including tremors, vomiting, poor feeding, poor weight gain and high-pitched
Oct 18, 2021 · Regular Session 2021-2022 Senate Bill 473. Text. [History] [Votes] Short Title: An Act amending Titles 35 (Health and Safety) and 75 (Vehicles) of the Pennsylvania Consolidated Statutes, providing for adult use cannabis, for medical marijuana, for lawful use and authority and for personal use of cannabis, establishing the Cannabis Regulatory ...
Jun 29, 2024 · June 29 – The PA-ACP is joining patients and advocates from across Pennsylvania in thanking state senators for unanimously passing Senate Bill 225, a vital piece of legislation that aims to curb restrictive prior authorization and step therapy (fail first) practices imposed by health insurers.
